Cite Filings / ALGS / 0001193125-22-134018

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Aligos Therapeutics, Inc. Filed 2022-04-29 Acc 0001193125-22-134018

Documents 1

DEFA14A Proxy Materials , d278991ddefa14a.htm

Around this filing

2023-04-28 DEFA14A Proxy Materials
2022-05-06 3 Initial Statement of Ownership
2022-05-04 8-K Results of operations
2022-05-04 10-Q Quarterly Report
2022-04-29 DEFA14A Proxy Materials
2022-04-29 DEF 14A Proxy Statement
2021-04-27 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d278991ddefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…